Efficacy evaluation of GCA treatment is primarily based on non-specific symptoms and laboratory markers. We aimed to assess the change in vascular inflammation in patients with large vessel (LV)-GCA under different treatments using [18F]FDG PET/CT.
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study / Schönau, Verena; Roth, Jessica; Tascilar, Koray; Corte, Giulia; Manger, Bernhard; Rech, Juergen; Schmidt, Daniela; Cavallaro, Alexander; Uder, Michael; Crescentini, Filippo; Boiardi, Luigi; Casali, Massimiliano; Spaggiari, Lucia; Galli, Elena; Kuwert, Torsten; Versari, Annibale; Salvarani, Carlo; Schett, Georg; Muratore, Francesco. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 60:8(2021), pp. 3851-3861. [10.1093/rheumatology/keab332]
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study
Galli, Elena;Salvarani, Carlo;Muratore, Francesco
2021
Abstract
Efficacy evaluation of GCA treatment is primarily based on non-specific symptoms and laboratory markers. We aimed to assess the change in vascular inflammation in patients with large vessel (LV)-GCA under different treatments using [18F]FDG PET/CT.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
